Quick Answer
RxSight, Inc. reported Stockholders Equity of $275.68 million for fiscal year 2025.
RxSight, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $275.68M | -2.0% |
| 2024 | $281.24M | +75.4% |
| 2023 | $160.36M | +78.4% |
| 2022 | $89.90M | -35.0% |
| 2021 | $138.24M | +132.1% |
| 2020 | -$430.59M | -2.6% |
| 2019 | -$419.81M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $275.97M | -0.5% | -0.7% |
| June 30, 2025 | $278.01M | +1.0% | -0.5% |
| March 31, 2025 | $279.32M | +70.4% | -0.7% |
| December 31, 2024 | $281.24M | +75.4% | +1.4% |
| September 30, 2024 | $277.26M | +71.7% | +0.7% |
| June 30, 2024 | $275.21M | +75.1% | +67.9% |
| March 31, 2024 | $163.93M | +13.0% | +2.2% |
| December 31, 2023 | $160.36M | +78.4% | -0.7% |
- RxSight, Inc. showed a decrease of -2.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, RxSight, Inc.’s stockholders equity has grown by 165.7% (from -$419.81 million to $275.68 million).
- The most recent figure is from RxSight, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: